A novel non-linear approach for establishing a QSAR model of a class of 2-Phenyl-3-(pyridin-2-yl) thiazolidin-4-one derivatives
In this investigation, we aimed to address the pressing challenge of treating osteosarcoma, a prevalent and difficult-to-treat form of cancer. To achieve this, we developed a quantitative structure-activity relationship (QSAR) model focused on a specific class of compounds called 2-Phenyl-3-(pyridin...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1263933/full |
_version_ | 1797671761783816192 |
---|---|
author | Leilei Wu Yonglin Chen Kangying Duan |
author_facet | Leilei Wu Yonglin Chen Kangying Duan |
author_sort | Leilei Wu |
collection | DOAJ |
description | In this investigation, we aimed to address the pressing challenge of treating osteosarcoma, a prevalent and difficult-to-treat form of cancer. To achieve this, we developed a quantitative structure-activity relationship (QSAR) model focused on a specific class of compounds called 2-Phenyl-3-(pyridin-2-yl) thiazolidin-4-one derivatives. A set of 39 compounds was thoroughly examined, with 31 compounds assigned to the training set and 8 compounds allocated to the test set randomly. The goal was to predict the IC50 value of these compounds accurately. To optimize the compounds and construct predictive models, we employed a heuristic method of the CODESSA program. In addition to a linear model using four carefully selected descriptors, we also developed a nonlinear model using the gene expression programming method. The heuristic method resulted in correlation coefficients (R2) of 0.603, 0.482, and 0.107 for R2cv and S2, respectively. On the other hand, the gene expression programming method achieved higher R2 and S2 values of 0.839 and 0.037 in the training set, and 0.760 and 0.157 in the test set, respectively. Both methods demonstrated excellent predictive performance, but the gene expression programming method exhibited greater consistency with experimental values. The successful nonlinear model generated through gene expression programming shows promising potential for designing targeted drugs to combat osteosarcoma effectively. This approach offers a valuable tool for optimizing compound selection and guiding future drug discovery efforts in the battle against osteosarcoma. |
first_indexed | 2024-03-11T21:20:14Z |
format | Article |
id | doaj.art-c5732484b69a413d913c93b21241f43b |
institution | Directory Open Access Journal |
issn | 1663-9812 |
language | English |
last_indexed | 2024-03-11T21:20:14Z |
publishDate | 2023-09-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Pharmacology |
spelling | doaj.art-c5732484b69a413d913c93b21241f43b2023-09-28T09:46:59ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-09-011410.3389/fphar.2023.12639331263933A novel non-linear approach for establishing a QSAR model of a class of 2-Phenyl-3-(pyridin-2-yl) thiazolidin-4-one derivativesLeilei WuYonglin ChenKangying DuanIn this investigation, we aimed to address the pressing challenge of treating osteosarcoma, a prevalent and difficult-to-treat form of cancer. To achieve this, we developed a quantitative structure-activity relationship (QSAR) model focused on a specific class of compounds called 2-Phenyl-3-(pyridin-2-yl) thiazolidin-4-one derivatives. A set of 39 compounds was thoroughly examined, with 31 compounds assigned to the training set and 8 compounds allocated to the test set randomly. The goal was to predict the IC50 value of these compounds accurately. To optimize the compounds and construct predictive models, we employed a heuristic method of the CODESSA program. In addition to a linear model using four carefully selected descriptors, we also developed a nonlinear model using the gene expression programming method. The heuristic method resulted in correlation coefficients (R2) of 0.603, 0.482, and 0.107 for R2cv and S2, respectively. On the other hand, the gene expression programming method achieved higher R2 and S2 values of 0.839 and 0.037 in the training set, and 0.760 and 0.157 in the test set, respectively. Both methods demonstrated excellent predictive performance, but the gene expression programming method exhibited greater consistency with experimental values. The successful nonlinear model generated through gene expression programming shows promising potential for designing targeted drugs to combat osteosarcoma effectively. This approach offers a valuable tool for optimizing compound selection and guiding future drug discovery efforts in the battle against osteosarcoma.https://www.frontiersin.org/articles/10.3389/fphar.2023.1263933/fullosteosarcomaQSARgene expression programmingmodelnon-linear |
spellingShingle | Leilei Wu Yonglin Chen Kangying Duan A novel non-linear approach for establishing a QSAR model of a class of 2-Phenyl-3-(pyridin-2-yl) thiazolidin-4-one derivatives Frontiers in Pharmacology osteosarcoma QSAR gene expression programming model non-linear |
title | A novel non-linear approach for establishing a QSAR model of a class of 2-Phenyl-3-(pyridin-2-yl) thiazolidin-4-one derivatives |
title_full | A novel non-linear approach for establishing a QSAR model of a class of 2-Phenyl-3-(pyridin-2-yl) thiazolidin-4-one derivatives |
title_fullStr | A novel non-linear approach for establishing a QSAR model of a class of 2-Phenyl-3-(pyridin-2-yl) thiazolidin-4-one derivatives |
title_full_unstemmed | A novel non-linear approach for establishing a QSAR model of a class of 2-Phenyl-3-(pyridin-2-yl) thiazolidin-4-one derivatives |
title_short | A novel non-linear approach for establishing a QSAR model of a class of 2-Phenyl-3-(pyridin-2-yl) thiazolidin-4-one derivatives |
title_sort | novel non linear approach for establishing a qsar model of a class of 2 phenyl 3 pyridin 2 yl thiazolidin 4 one derivatives |
topic | osteosarcoma QSAR gene expression programming model non-linear |
url | https://www.frontiersin.org/articles/10.3389/fphar.2023.1263933/full |
work_keys_str_mv | AT leileiwu anovelnonlinearapproachforestablishingaqsarmodelofaclassof2phenyl3pyridin2ylthiazolidin4onederivatives AT yonglinchen anovelnonlinearapproachforestablishingaqsarmodelofaclassof2phenyl3pyridin2ylthiazolidin4onederivatives AT kangyingduan anovelnonlinearapproachforestablishingaqsarmodelofaclassof2phenyl3pyridin2ylthiazolidin4onederivatives AT leileiwu novelnonlinearapproachforestablishingaqsarmodelofaclassof2phenyl3pyridin2ylthiazolidin4onederivatives AT yonglinchen novelnonlinearapproachforestablishingaqsarmodelofaclassof2phenyl3pyridin2ylthiazolidin4onederivatives AT kangyingduan novelnonlinearapproachforestablishingaqsarmodelofaclassof2phenyl3pyridin2ylthiazolidin4onederivatives |